476 related articles for article (PubMed ID: 30470618)
1. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
3. First Line Treatments for Newly Diagnosed Primary Immune Thrombocytopenia in Children: A Systematic Review and Network Meta-analysis.
Acero-Garcés DO; García-Perdomo HA
Curr Pediatr Rev; 2020; 16(1):61-70. PubMed ID: 31656149
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
[TBL] [Abstract][Full Text] [Related]
5. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Gedik Y; Orhan F
Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
[TBL] [Abstract][Full Text] [Related]
6. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
Ozsoylu S; Sayli TR; Oztürk G
Pediatr Hematol Oncol; 1993; 10(4):317-21. PubMed ID: 8292515
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
Duru F; Fisgin T; Yarali N; Kara A
Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
Cooper N
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute immune thrombocytopenic purpura.
Tarantino MD; Goldsmith G
Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
[TBL] [Abstract][Full Text] [Related]
11. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
[TBL] [Abstract][Full Text] [Related]
12. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
14. Immune thrombocytopenic purpura.
Gupta V; Tilak V; Bhatia BD
Indian J Pediatr; 2008 Jul; 75(7):723-8. PubMed ID: 18716743
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura.
Pruemer J
Am J Health Syst Pharm; 2009 Jan; 66(2 Suppl 2):S4-10. PubMed ID: 19139489
[TBL] [Abstract][Full Text] [Related]
16. Management of immune thrombocytopenic purpura in children: potential role of novel agents.
Bredlau AL; Semple JW; Segel GB
Paediatr Drugs; 2011 Aug; 13(4):213-23. PubMed ID: 21692546
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic thrombocytopenic purpura in Egyptian children.
Khalifa AS; Tolba KA; el-Alfy MS; Gadallah M; Ibrahim FH
Acta Haematol; 1993; 90(3):125-9. PubMed ID: 8291370
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
Higashide Y; Hori T; Yoto Y; Kabutoya H; Honjo S; Sakai Y; Nojima M; Yoda M; Yamamoto M; Tsutsumi H
Pediatr Int; 2018 Apr; 60(4):357-361. PubMed ID: 29297955
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
Blanchette V; Carcao M
Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
[TBL] [Abstract][Full Text] [Related]
20. Recurrent immune thrombocytopenic purpura in children.
Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
